CCAAT/enhancer binding protein δ (C/EBPδ) expression and elevation in Alzheimer’s disease
- 9 April 2004
- journal article
- Published by Elsevier
- Vol. 25 (8) , 991-999
- https://doi.org/10.1016/j.neurobiolaging.2003.10.016
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- C/EBPα: a critical regulator of genes governing integrative metabolic processesPublished by Elsevier ,2002
- Role of nuclear factor kappa B in neuropathological mechanismsPublished by Elsevier ,2001
- Inflammation and Alzheimer's diseaseNeurobiology of Aging, 2000
- Pro-inflammatory cytokines induce the transcription factors C/EBP? and C/EBP? in astrocytesGlia, 2000
- Ethanol rapidly inhibits IL‐6‐activated STAT3 and C/EBP mRNA expression in freshly isolated rat hepatocytesFEBS Letters, 1999
- Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion.Circulation, 1999
- β-Adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein δProceedings of the National Academy of Sciences, 1998
- Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP alpha, -beta, and -delta during granulocyte-lineage specification.Proceedings of the National Academy of Sciences, 1996
- Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolismJournal of Neuroscience, 1996
- Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor GeneJournal of Biological Chemistry, 1995